Paragon Care (ASX:PGC) was advised by administrators that a preliminary estimated outcome analysis for the Infinity Retail Pharmacy Group administration indicates it will receive a distribution of about AU$11.7 million to AU$15.8 million, representing a recovery of around 24% to nearly 33% of its outstanding exposure, according to a Monday Australian bourse filing.

The company said it has already received a cash recovery of AU$3.4 million from the Australian Taxation Office relating to goods and services tax previously paid on the Infinity Group receivable.

Paragon Care expects fiscal year 2026 revenue of about AU$3.7 billion, with underlying earnings before interest, taxes, depreciation, and amortization in the range of AU$95 million to AU$100 million, it added.